GCIA
PRVL

Gabelli & Co Investment Advisers’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-205,800
Closed -$4.75M – 527
2020
Q4 		$4.75M Buy
+205,800
New +$4.75M 0.74% 32